Deakin University
Browse

Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective

Version 2 2024-06-05, 10:29
Version 1 2023-01-27, 05:17
journal contribution
posted on 2024-06-05, 10:29 authored by Feby SaviraFeby Savira, BH Wang, AR Kompa, Z Ademi, A Owen, A Tonkin, S Zoungas, D Liew, E Zomer
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective

History

Journal

EUROPEAN HEART JOURNAL

Volume

41

Pagination

1051-1051

Location

ELECTR NETWORK

Publisher DOI

Start date

2020-08-29

End date

2020-09-01

ISSN

0195-668X

eISSN

1522-9645

Language

English

Author URL

Publication classification

E3.1 Extract of paper

Publisher

OXFORD UNIV PRESS

Usage metrics

    Research Publications

    Categories

    Keywords

    Science & TechnologyLife Sciences & BiomedicineCardiac & Cardiovascular SystemsCardiovascular System & Cardiology

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC